Pura Vida Investments, LLC Xenon Pharmaceuticals Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $636,000 - $878,999	25,000 Added 166.64%	40,002 $1.22 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $840,515 - $1.11 Million	-33,500 Reduced 69.07%	15,002 $459,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $23,368 - $53,029	-1,498 Reduced 3.0%	48,502 $1.52 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $743,000 - $972,500	50,000 New	50,000 $764,000
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $675,000 - $1.12 Million	-75,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.8 - $9.2 $360,000 - $690,000	75,000 New	75,000 $690,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.